Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28

LAVAL, Quebec, Feb. 6, 2018 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its fourth-quarter and full-year 2017 financial results on Wednesday, Feb. 28, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.

 

Conference Call Details
Date:	Wednesday, Feb. 28, 2018
Time:	8:00 a.m. EST
Webcast:	http://ir.valeant.com/events-and-presentations
Participant Event Dial-in:	[phone] (North America)
	[phone] (International)
Participant Passcode:	5287247
Replay Dial-in:	[phone] (North America)
	[phone] (International)
Replay Passcode:	5287247 (replay available until Apr. 28, 2018)

 

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

 

Investor Contact:	Media Contact:
Arthur Shannon	Lainie Keller
[e-mail]	[e-mail]
[phone]	[phone]
[phone] (toll free)

 

 

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-will-release-fourth-quarter-and-full-year-2017-financial-results-on-february-28-300594219.html

SOURCE Valeant Pharmaceuticals International, Inc.

Copyright 2018 Canada NewsWire